Related Experiment Video
Updated: Jul 9, 2026
18:25
Orthotopic Liver Transplantation in Rats
Published on: July 1, 2012
Liver transplantation: an update
R C Verdonk1, A P van den Berg, M J H Slooff
1Department of Gastroenterology & Hepatology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands. r.c.verdonk@int.umcg.nl
The Netherlands Journal of Medicine
|December 7, 2007
Summary
Liver transplantation is a successful treatment for end-stage liver disease, with improving survival rates and expanding indications. Ongoing challenges include donor organ shortages and managing long-term recipient health.
Area of Science:
- Hepatology
- Transplant Surgery
- Immunology
Background:
- Liver transplantation has been a standard treatment for end-stage liver disease since the 1980s.
- Significant advancements have improved care for liver transplant candidates and recipients.
- Current one- and five-year patient survival rates are approximately 85% and 75%, respectively.
Purpose of the Study:
- To provide a comprehensive update on recent developments in liver transplantation.
- To highlight progress in patient care, recipient selection, and long-term management.
- To address challenges such as donor organ scarcity and evolving indications.
Main Methods:
- Review of recent literature and clinical practice in liver transplantation.
- Analysis of trends in patient survival, indications, and contraindications.
- Discussion of innovations in perioperative care and long-term follow-up strategies.
Main Results:
- Indications for liver transplantation are broadening, with decreasing contraindications.
- The Model for End-Stage Liver Disease (MELD) score is a key tool for recipient selection.
- Perioperative care is highly standardized, with reduced blood loss during procedures.
- Long-term care focuses on managing recurrent diseases, de novo malignancies, and cardiovascular conditions.
Conclusions:
- Liver transplantation is a highly successful therapy with improving outcomes.
- Addressing donor organ shortages and optimizing long-term recipient health are critical.
- The goal is to achieve normal life expectancy and quality of life for transplant recipients.
